Lansoprazole indications: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
m (Undo revision 619142 by AkylaHtFZ (talk))
 
Line 1: Line 1:
{{CMG}}
{{CMG}}
PREVACID® NapraPACTM (250, 375 or 500) is indicated for reducing the risk of NSAID-associated
===Indications===
Lansoprazole is indicated for reducing the risk of NSAID-associated
gastric ulcers in patients with a history of documented gastric ulcer who require the use of an NSAID
gastric ulcers in patients with a history of documented gastric ulcer who require the use of an NSAID
for treatment of the signs and symptoms of rheumatoid arthritis, osteoarthritis, and ankylosing
for treatment of the signs and symptoms of rheumatoid arthritis, osteoarthritis, and ankylosing

Latest revision as of 16:04, 20 December 2011

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Indications

Lansoprazole is indicated for reducing the risk of NSAID-associated gastric ulcers in patients with a history of documented gastric ulcer who require the use of an NSAID for treatment of the signs and symptoms of rheumatoid arthritis, osteoarthritis, and ankylosing spondylitis.



Adapted from the FDA Package Insert.